AstraZeneca
AZN · LONDON
Who owns AZN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 19.9% of AZN’s shares.
- Investor AB3.3%
- Vanguard Capital Management, LLC2.9%
- Capital International Investors2.2%
- Norges Bank Investment Management (NBIM)2.2%
- Next 6 largest institutions9.2%
- All other shareholders80.1%
| Holder | Shares | % of shares |
|---|---|---|
| Investor AB | 51.59M | 3.33% |
| Vanguard Capital Management, LLC | 45.39M | 2.93% |
| Capital International Investors | 34.58M | 2.23% |
| Norges Bank Investment Management (NBIM) | 33.86M | 2.18% |
| Capital World Investors | 30.08M | 1.94% |
| Wellington Management Company, LLP | 28.54M | 1.84% |
| Legal & General Investment Management Ltd. | 25.75M | 1.66% |
| Fidelity Management & Research Company LLC | 21.54M | 1.39% |
| Vanguard Asset Management Ltd | 18.71M | 1.21% |
| PRIMECAP Management Company | 18.10M | 1.17% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Statens Pensjonsfond Utland | 33.84M | 2.18% |
| Vanguard Total International Stock Index Fund | 22.06M | 1.42% |
| American Funds New Perspective Fund | 16.85M | 1.09% |
| Vanguard Developed Markets Index Fund | 14.72M | 0.95% |
| Vanguard PRIMECAP Fund | 11.92M | 0.77% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $3.21K (1 trade) and sold $2.21M (1 trade) of AZN on the open market.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Sharma Mani | Award | 2 | $320 |
| Sharma Mani | Award | 1 | $163 |
| Sharma Mani | Buy | 20 | $3.21K |
| Sharma Mani | Award | 2 | $327 |
| Sharma Mani | Award | 2 | $381 |
| Sharma Mani | Award | 1 | $180 |
| Sharma Mani | Sale | 11.89K | $2.21M |
Congressional trades
Disclosed by members of Congress over the last 12 months
| Member | Type | Amount | Traded |
|---|---|---|---|
| Alan ArmstrongSenator | Purchase | $1K–$15K | Mar 31, 2026 |
| Alan ArmstrongSenator | Purchase | $15K–$50K | Mar 30, 2026 |
| Gil CisnerosHouse | Purchase | $1K–$15K | Dec 18, 2025 |
| Julia LetlowHouse | Purchase | $1K–$15K | Dec 8, 2025 |
| Gil CisnerosHouse | Purchase | $1K–$15K | Nov 19, 2025 |
| Lisa McClainHouse | Sale | $1K–$15K | Oct 31, 2025 |
| Lisa McClainHouse | Purchase | $1K–$15K | Oct 30, 2025 |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.62M
- Days to cover
- 1.00
- % of shares outstanding
- 0.17%
- Average daily volume
- 2.81M
- Change since last report
- +25.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.